Is a complete AIM/POLB research report available?

Question

Accepted Answer

No complete published report is available for aim/POLB (AIM/POLB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	64.1M
Net income (ttm)	-5.7M
EPS (ttm)	-GBX 0.01
Shares out	763.4M
Volume	1,298,631
Beta	1.83

Metric	Value
Country	United Kingdom
Country code	UK
Employees	15
Employees Change	-1%
Employees Change Percent	-6.25
Enterprise value	GBX 56.4M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BKPG7Z60
Last refreshed	2026-09-11
Market cap	GBX 64.1M
Price	GBX 8.4
Price currency	GBX
Sector	Healthcare
Sector PE	20.62
Sector PE Fwd	13.37
Sic	2834
Symbol	aim/POLB
Website	https://www.poolbegpharma.com

Metric	Value
Earnings Yield	-8.88%
FCF yield	-7.42%
P/B ratio	7.46x

Metric	Value
Net Income	GBX -5.7M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	GBX -379,667
ROA	-39.2
ROCE	-73.61
ROE	-63.72
ROIC	-44.28

Metric	Value
Cagr1y	95.44%
Cagr3y	5.76%
Cagr5y	-6.89%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

AIM/POLB (AIM/POLB)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/POLB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/POLB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/POLB

Frequently asked questions

Metric	Value
Assets	GBX 9.9M
Cash	GBX 7.7M
Current Assets	GBX 8.3M
Current Liabilities	GBX 1.3M
Debt	GBX 0
Equity	GBX 8.6M
Liabilities	GBX 1.3M
Long Term Assets	GBX 1.7M
Long Term Liabilities	GBX 0
Net Cash	GBX 7.7M
Net Cash By Market Cap	GBX 12.03
Net Cash Growth	-1.42%
Net Debt Equity	GBX -0.9
Tangible Book Value	GBX 6.9M
Tangible Book Value Per Share	GBX 0.01
WACC	14.3

Metric	Value
Current ratio	6.17
Net Working Capital	GBX -786,000
Quick ratio	5.97
Working Capital	GBX 6.9M

Metric	Value
1Y total return	95.35%
200-day SMA	5.52
3Y total return	18.31%
50-day SMA	7.55
50-day SMA vs 200-day SMA	50over200
5Y total return	-30%
All Time High	15.77
All Time High Change	-46.72%
All Time High Date	2024-05-07
All Time Low	2.25
All Time Low Change	273.33%
All Time Low Date	2025-04-07
ATR	0.35
Beta	1.83
Beta1y	0.75
Beta2y	1.01
Ch YTD	110
High	8.5
High52	9.2
High52 Date	2026-08-21
High52ch	-8.7%
Low	8.33
Low52	3.3
Low52 Date	2025-11-24
Low52ch	154.55%
Ma50ch	11.33%
Price vs 200-day SMA	52.15%
RSI	54.77
RSI Monthly	63.01
RSI Weekly	65.52
Sharpe ratio	1.24x
Sharpe Ratio3y	0.37x
Sharpe Ratio5y	0.21x
Sortino ratio	2.17
Sortino Ratio3y	0.69
Sortino Ratio5y	0.45
Total Return	-20.53%
Tr YTD	110
Tr1m	1.21%
Tr1w	-2.1%
Tr3m	9.09%

Metric	Value
Float	553,779,614%
Shares Insiders	16.95%
Shares Institutions	52.05%
Shares Out	763,437,106
Shares Qo Q	37.95%
Shares Yo Y	20.53%

Metric	Value
Adjusted FCF	GBX -5.3M
Adjusted OCF	-5,307,000
Average Volume	2,112,876x
Bv Per Share	0.01
Ch1m	1.21
Ch1w	-2.1
Ch1y	95.35
Ch3m	9.09
Ch3y	18.31
Ch5y	-30
Ch6m	100
Change	0.6%
Change From Open	0
Close	8.35
Days Gap	0.6
Depreciation Amortization	59,000
Dollar Volume	10,908,500.4
Earnings Date	2026-09-18
EBIT	GBX -6.3M
EBITDA	GBX -6.3M
EPS	GBX -0.01
F Score	1
FCF	GBX -4.8M
FCF EV Yield	-8.44x
FCF Per Share	GBX -0.01
Financing CF	4,477,000
Fiscal Year End	December
Founded	2,021
Income Tax	GBX -79,000
Investing CF	173,000
Is Primary Listing	1
Last Earnings Date	2026-01-02
Last Report Date	2025-12-31
Ma150	5.97
Ma150ch	40.61%
Ma20	8.54
Ma20ch	-1.59%
Net CF	-111,000
Next Earnings Date	2026-09-18
Open	8.4
Position In Range	41.18
Price Date	2026-09-10
Ptbv Ratio	9.26
Relative Volume	0.54x
Share Based Comp	546,000
Tr6m	100%
Volume	1,298,631